Lwvolin dosage in pediatrics
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive dosing data from the Red Book 2021. Let me compile this into a clear answer.
Levofloxacin (Levaquin) Dosing in Pediatrics
Note on use in children: Fluoroquinolones, including levofloxacin, should not be used routinely as first-line agents in children <18 years. They are reserved for situations where specific indications exist or no alternative agents are available. Use judiciously to limit resistance. — Red Book 2021, p. 1317–1318
General Dosing (Beyond the Newborn Period)
| Weight/Age | Route | Dose | Max |
|---|---|---|---|
| ≥6 months and <50 kg | IV or PO | 8 mg/kg twice daily (i.e., 16 mg/kg/day in 2 divided doses) | 500 mg/day |
| >50 kg | IV or PO | 500 mg once daily (flat dose, not per kg) | — |
— Red Book 2021 (AAP), Antibacterial Drugs for Pediatric Patients, p. 1342
Indication-Specific Dosing
Drug-Resistant Tuberculosis (MDR-TB)
| Population | Dose | Max | Frequency |
|---|---|---|---|
| Children | 15–20 mg/kg/day | 1 g/day | Once daily |
| Adults | 750–1000 mg/day | 1 g/day | Once daily |
— Red Book 2021, Table 3.80: Drugs for Treatment of Drug-Resistant TB Disease, p. 1234
Anthrax (Post-Exposure Prophylaxis or Treatment)
| Weight | Dose | Frequency |
|---|---|---|
| <50 kg | 8 mg/kg/dose (max 250 mg/dose) | Twice daily |
| ≥50 kg | 500–750 mg | Once daily |
— Goldman-Cecil Medicine, Postexposure Prophylaxis section
Safety Considerations in Children
- Transient arthralgia has been reported (reversible); no confirmed long-term bone/joint sequelae with levofloxacin or moxifloxacin to date
- Risk of tendinitis/tendon rupture (all ages)
- Theoretical effect on growing cartilage (based on animal models)
- Can prolong QTc interval — monitor ECG in at-risk patients
- Associated with C. difficile disease risk
- Avoid in neonates — no established dosing in this age group
— Red Book 2021, Fluoroquinolones section, p. 1317–1318
In summary: The standard pediatric dose for most indications is 8 mg/kg twice daily (≥6 months, <50 kg) up to a maximum of 500 mg/day, or 500 mg once daily for children weighing >50 kg. For MDR-TB, higher doses of 15–20 mg/kg/day are used.
This is a shared conversation. Sign in to Orris to start your own chat.